Acquiring Company
Bristol Myers Squibb
Acquired Company
Medarex
LawrencevillePrincetonManufacturingBiotechnologyProfessional ServicesHealth CareMedicalTherapeuticsPharmaceuticalLegalBiopharmaLaw EnforcementBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Bristol-Myers Squibb has acquired Medarex to enhance its cancer treatment capabilities. This acquisition is pivotal for the company's development pipeline, bringing a promising drug targeting melanoma. With this strategic move, Bristol-Myers aims to solidify its leadership in oncology and expand treatment options for various cancers.
Fundz sees it the moment Bristol Myers Squibb makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Medarex?
Medarex was acquired by Bristol Myers Squibb, based in Lawrenceville. The deal was reported on August 2, 2026. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb is publicly traded (BMY) and operates in Manufacturing.
When did Bristol Myers Squibb acquire Medarex?
Bristol Myers Squibb's acquisition of Medarex was reported on August 2, 2026. Bristol-Myers Squibb has acquired Medarex to enhance its cancer treatment capabilities. This acquisition is pivotal for the company's development pipeline, bringing a promising drug targeting melanoma. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Medarex do?
Medarex was a biopharmaceutical company that focused on developing monoclonal antibody therapies for cancer and other diseases. Known for its innovative approaches, Medarex contributed to significant advancements in cancer treatment. It is privately held, operating in Biotechnology, and is based in Princeton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.